An international survey presented at the second annual ESC Cardio-Oncology 2026 conference has uncovered significant deficiencies in structured training programmes for cardio-oncology specialists across multiple healthcare systems. The findings highlight a critical disconnect between the expanding clinical need to manage cardiovascular complications in cancer patients and the limited availability of formal educational pathways to prepare clinicians for this specialised intersection of cardiology and oncology.
As modern cancer therapies—including targeted agents and immunotherapies—continue to demonstrate cardiotoxic risks, the demand for cardio-oncology expertise has intensified. However, current training infrastructure remains fragmented and inconsistent globally. The survey results underscore the urgency of developing coordinated, international curriculum standards to address this gap and ensure clinicians are adequately prepared to care for cancer survivors with concurrent cardiovascular disease.
Read the full article on GMJ Newsroom.
Was this article helpful?
